Hrt Financial LP Laboratory Corp Of America Holdings Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$197.69 - $227.29 $15.1 Million - $17.4 Million	76,464 New	76,464 $17.4 Million
Q1 2023 May 12, 2023	BUY	$213.32 - $257.83 $374,589 - $452,749	1,756 New	1,756 $402,000
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $10.9 Million - $13.9 Million	53,088 New	53,088 $10.9 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $1.09 Million - $1.25 Million	-4,176 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $637,988 - $738,079	2,349 Added 128.57%	4,176 $1.31 Million
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $502,096 - $563,337	1,827 New	1,827 $514,000
Q3 2020 Nov 13, 2020	SELL	$167.03 - $201.3 $1.06 Million - $1.28 Million	-6,358 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $720,424 - $1.16 Million	6,358 New	6,358 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$159.77 - $178.1 $4.13 Million - $4.6 Million	-25,848 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $3.44 Million - $4.12 Million	23,847 Added 1191.75%	25,848 $4.47 Million
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $247,523 - $312,756	2,001 New	2,001 $306,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.